| Organism : | Gallus gallus | ||
| Protein family description: | Acyl-CoA synthetase long-chain family. | ||
| Gene | Description | Genome localization | |
| ACSF2 | 3_random: 1048104-1077115 | ||
| ACSL1 | acyl-CoA synthetase long-chain family member 1 [Source:RefSeq_peptide;Acc:NP_001012596] | 4: 40052517-40081050 | |
| ACSL3 | Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3). [Source:Uniprot/SWISSPROT;Acc:O95573] [from human gene ENSG00000123983] | 9: 5550261-5574333 | |
| ACSL4 | Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4). [Source:Uniprot/SWISSPROT;Acc:O60488] [from human gene ENSG00000068366] | 4: 13530456-13543222 | |
| RCJMB04_26g6 | similar to fatty acid Coenzyme A ligase, long chain 5; long-chain fatty acid coenzyme A ligase 5 [Source:RefSeq_peptide;Acc:NP_001026408] | 6: 25769823-25781999 | |
| ACSL6 | Fatty acid Coenzyme A ligase, long chain 6 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q5W4S3] | 13: 15672654-15690349 | |
FACL sequence(s) for Gallus gallus and PTS predictions
Non-significant PTS1, PTS2, PEX19 prediction reported |
|
SYIQGTLDIPLINKTVGQCLDETAERFPHRDAFVFYRDGVRKTFAQFKEEVDQAAAGLLALGLMKGDRLGMWGPNKYEWVLMQFATAQAGIILVSV NPAYQAHELEFVMRKVGCKALVFPSHFKSQKYYDILKQSCPEVENSSPGGIKSKRLPDLSTVIMLDSKLPGTFHMDEVMQAGDSSHMKQLRALQQT LSCNEPVNIQFTSGTTGSPKGATLSHRNIVNNANLIGMRLGITEQRCCAEDYRVCIPAPLYHCLASVGGCMVSALHGSSCVFSAPSFEGKATLEAV SQEKCSFLHGTPTMFIDMLSQPDFDSYNLSSLRGGVIAGSPVPPEIMKVVSTKMHMPEVMVAYGTTENSPVTFMGFPTDDITRRTETVGSILPHTE AKIEDPETRKPVPLNTPGELQVRGYCVMLGYWNDSARTREVISDDNWYKTGDIATLDEHGYCRIIGRCKDMIIRGGENIYPAEIEQFLHTHPKVEE VQVVGVKDSRMGEEVCACIRLRAGQSCAADDIKAFCKGKISHFKIPRYVVFVNQYPLTVSGKVQKYKLREQMEKHLQL |
Non-significant PTS1, PTS2, PEX19 prediction reported |
|
LMWLSQKYVRTLPTNTLVGFGAFAALTTYWYATRPKALKPPCDLAMQSVKVEGEEDARRSSLLNSDELITCYYDDVRTVYDIFQRGLHVSNNGPCL GVRKPNQPYEWISYKEVSDRAEYVGSALLHRGFKPSHSQYVGIFAQNRPEWVIIEQSCYTYSMVVVPLYDTLGTEAITYIVNKADLSLVFCDTPEK AKLLLTAVEKGETPILSTIVIMEPFGTDLLERGKKCGVEVFSMKEIEELGKAHRQKPILPKPEDLAVICFTSGTTGNPKGAMITHKNIVSNSSAFL KTTEKTFIPTPEDVLISFLPLAHMFERIVECVVLCHGARIGFFQGDIRLLMDDLKTLQPTVFPVVPRLLNRMFDKIFGQADTSLKKWMLDFASKRK EAELRSGIIRNNSFWDKVIFRKIQASLGGKVRLMVTGAAPVSASVLTFLRTALGCQFYEGYGQTECTAGCSLSMPGDWTAGHVGAPMACNIIKLVD VQEMNYLAAKGEGEVCVKGPNVFLGYLKDPEKTAEALDKDGWLHTGDIGKWLPNGTLKIIDRKKHIFKLAQGEYIAPEKIENVYLRSEALAQVFVH GESLQAFLLAVVVPDPETLCKWAKKKGFEGTYEKLCKNKDVKKHILEDMVRVGKESGLKSFEQVKDIIVHTEMFSIENGLLTPTLKAKRPELRKYF QSQIDELYANTKM |
Non-significant PTS1, PTS2, PEX19 prediction reported |
|
SQGAKMKLKHNINPVLLQFINFIILVYTVVTYIPWYIFSGSRQAIAKSKQVKARPVNNRPGGAYRSVNSLHCLASVLYPGCDTLDKVFKYAKTKYK DKKLLGTREILKEEDEIQPSGKVFKKVILGKYTWLSYEDVYIKAVNFGNGLAVLGQQPKTNIAIFCETRAEWMIAAQACFMCNYQLVTLYATLGGA AIVHGLNETEVTTIITSKELMQTKLKEIVSQIPRLRHIITVDGKPTTWSEFPKGVIVHTMASVQAMGAKADSGNKQQARPVPSDIAVIMYTSGSTG IPKGVMISHCNIIAGITGMAERIPNLGEKDIYIGYLPLAHVLELSAELVCLSHGCRIGYSSPQTLADQSSKIKKGSKGDVTTLKPTLMAAVPEIMD RIYKNVMNKVNEMTSFQRNLFILAYNYKMEQISKGYTTPLCDSLIFRKVRMLLGGKIRILLCGGAPLSAATQRFMNICFCCPVGQGYGLTESAGAG TITEVWDYTTGRVGAPLVCCEIKLLNWEEGGYYNTDKPYPRGEILIGGQNVTVGYYKNEGRTRKDFTIDENGQRWLHTGDIGEFHQDGCLKIIAID RKKDLVKLQAGEYVSLGKVEAALKNLPLVDNICAYASSFHSYVIGFVVPNQKELAELARKKGFKGTWEEICNSSEMEKEVLKVLAEAAMAANLEKF EIPVKIRLSPDPWTPETGLVTDAFKLKRKELTAYYQKDIDRMYGTN |
Non-significant PTS1, PTS2, PEX19 prediction reported |
|
LRDFLFQIPTMKLRLEVCAILLLPVYLLISVYSMLVFIPWYFLTNAKKKKAMAKRLKAKPISDKPGSPYRSVTHLDSLANINIPGADTLDKLFDHA LAKFGKKDCLGTREILSEENEMQPNGKVFKKLILGTYRWLSYEEVNQKVNRLGSGLIALGLTPKSTVVIFCETRAEWMIAALACFKYNFPLVTLYA TLGEEAVTYGLNECGASYLITSAELLESKLKATLPQISCLKHIIYVDNKNINKSEYPENVEIHSMQTVEELGAKPENASIQPSRPVPTDLALVMYT SGSTGRPKGVMMQHKNLIAGMTGQCERIPGLGPKDTYIGYLPLAHVLELTAEISCITYGCRIGYSSPLTLSDQSSKIKKGSKGDCTVLKPTLMAAV PEIMDRIYKNVMSKVQEMNYIQRTLFKIGYDYKLEQIKRGYDAPLCNILLFKKVKALLGGNIRMMLSGGAPLSPQTQRFMNICFCCPVGQGYGLTE TCGAGTITEVADYSTGRVGAPLICCEIRLRDWQEGGYTNRDKPNPRGEIIIGGPNVSMGYFKNEEKTTEDFTIDENGQRWFCTGDIGEFHPDGCLQ IIDRKKDLVKLQAGEYVSLGKVEAALKNCSLIDNICAYAKSSDQSYVISFVVPNQKKLTALAEQKGISGTWVEICNNPTMEAEILREIKEVANKMK LERFEIPIKVRLSPEPWTPETGLVTDAFKLKRKELKNHYLNDIERMYGGK |
Non-significant PTS1, PTS2, PEX19 prediction reported |
|
FDVHVVTQNVELPKHVFISREHIRTLPTPALFTLIAFGALIFLWVVSRPKPVLPPVDLNKQSVGIEGGARRAALLTDNNLVSYYFEDSKTLYEAFQ RGLHASGNGNCLGYRKPNQPYQWLTYKQVLDRAQHLGSGLLQKGCKPSSDQFIGIFAQNRPEWIISEYACYTYSMVAVPLYDTLGPDAILYIVNKA DIGIVICDKPEKAQILLENCEQGKTPCLKTIILMDLFDKELKDRGAKVGVEILALQEAEELGRNNIRKPVPPGPEDLCIVCFTSGTTGNPKGAMLT HENVVANAAAFLRTIEDTVECTTSDVSISYLPLAHMFERVVQTVMYSCGAKVGFFQGDIKLLTDDMKTLKPTIFPVVPRLLNRIYDKIQSGANTPM KKFLLNFAATMKMIEVKQGIIRNDSLLDKLVFKKVQETMGGRVRIMVTGAAPISPSVLKFLRSALGCQVFEAYGQTECSAGCTFSMPGDWTTVGHV GPPLVCNIIKLDDVEEMNYFSSNNEGEVCIKGPNVFKGYLKDPEKTAEAIDKDGWLHTGDVGKWMPNGTLKIIDRKKNIFKLAQGEYIAPEKIENV YIRSVAVAQVFVHGESLRSCLIGIVVPDAETLPEFAAKLGIKGSYEDICKNPAVKKAILEDLVRLGKAAGLKSFEQVKDLYIHTELFSVENGLLTP TLKAKRAELVKVFQKQIEALYSSMQE |
Non-significant PTS1, PTS2, PEX19 prediction reported |
|
LAELTVSLVEKMQAQEILRSLRLPEFDDLSQFFRNLPATALVGIGAFAAVVAYWFASRPKAVKPPCDLRMQSEEVEGLDGARRSVIGDSPQLLTHY YDDARTMYEVFRRGFSISENGPCLGYRKPKQPYQWLSYKEVAERAEALGSGLLQQGCKPCTEQFIGVFAQNRPEWIISELACYTYSMVVVPLYDTL GPGAIRYIVNTADISTVICDKPDKARTLLDHVERRETPGLSSIILMDPFEKELTERGRRCGVRIQSMQEVEDCGRENRRAPVPPRPEDLSIVCFTS GTTGNPKGAMLTHGNVVADFSGFLKVTEKVIFPRQDDVLISFLPLAHMFERVIQSVVYCHGGRIGFFQGDIRLLSDDMKALRPTIFPVVPRLLNRM YDKIFSQADTSLKRWVLEFAARRKKAEVRNGIIRNDSLWDKLFFNKIQASLGGCVRMIVTGAAPASPTVLGFLRAALGCQVYEGYGQTECTAGCTF TTPGDWTSGHVGAPLPCNLIKLKDAEELNYFASKGEGEICVKGPNVFKGYLKDEERTSEALDQEGWLHTGDIGKWLPNGTLKIIDRKKHIFKLAQG EYIAPEKIENIYIRSDPVAQVYVHGDSLQAFLVGIVVPDAEAMPGWAKKRGFDGTYEELCRNKELQKAIMEDMVRLGKESGLHSFEQVKAIHIHSD MFSVQNGLLTPTLKAKRPELRDYFKKQIEELYSSISI |